先天性心脏病继发性肺淋巴管扩张症的诊断:胸部超声的新作用及预后意义
前瞻性观察研究对26例左心发育不良综合征、完全性肺静脉异位连接或三房心患儿行胸部超声,其中13例存在肺静脉梗阻。梗阻组11/13(84.6%)临床和/或活检诊断继发性肺淋巴管扩张症。不规则肺表面、胸膜下囊性结构及两者组合为有统计学意义的超声诊断标准,合并者死亡7/11(63.6%)。
要点
- 肺静脉梗阻患儿中,胸部超声见不规则肺表面、胸膜下囊性结构及两者组合支持继发性肺淋巴管扩张症诊断。
- 胸膜下囊性结构与肺表面不规则同时出现时似然比最高(LR 10.9,95%CI 1.6-75.0)。
- 继发性肺淋巴管扩张症患儿随访中死亡比例较高(7/11,63.6%),主要死于心肺衰竭或并发症。
核心结论
- 胸部超声是诊断肺静脉梗阻患者继发性肺淋巴管扩张症的准确且可重复的床旁方法,这些患者可能预后更差。
研究设计与样本
- 前瞻性观察研究,纳入26例左心发育不良综合征、完全性肺静脉异位连接或三房心患儿,其中13例有肺静脉梗阻、13例无梗阻,行胸部超声并记录继发性肺淋巴管扩张症超声特征、评估诊断性能,并回顾继发性肺淋巴管扩张症患儿临床病程。
关键影像表现/征象
- 有统计学意义的胸部超声诊断标准包括不规则肺表面(似然比6.8,95%CI 1.9-25.1)。
- 有统计学意义的胸部超声诊断标准包括胸膜下囊性结构(似然比3.6,95%CI 1.2-10.7)。
- 胸膜下囊性结构与肺表面不规则组合的似然比为10.9(95%CI 1.6-75.0)。
诊断标准与关键数值
- 梗阻组13例中11例(84.6%)经临床和/或活检诊断继发性肺淋巴管扩张症。
- 不规则肺表面诊断继发性肺淋巴管扩张症的似然比为6.8(95%CI 1.9-25.1)。
- 胸膜下囊性结构诊断继发性肺淋巴管扩张症的似然比为3.6(95%CI 1.2-10.7)。
- 胸膜下囊性结构与肺表面不规则组合诊断继发性肺淋巴管扩张症的似然比为10.9(95%CI 1.6-75.0)。
临床应用与阅片要点
- 对左心发育不良综合征、完全性肺静脉异位连接或三房心合并肺静脉梗阻的患儿,床旁胸部超声可评估不规则肺表面和胸膜下囊性结构以辅助诊断继发性肺淋巴管扩张症。
- 胸膜下囊性结构与肺表面不规则同时出现时似然比最高,可提高诊断信心。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Secondary pulmonary lymphangiectasia is a complication of congenital heart disease that results from chronic pulmonary venous obstruction.
OBJECTIVES: We aimed to evaluate the performance of chest ultrasound (US) in diagnosing secondary pulmonary lymphangiectasia and to review the clinical course of children with secondary pulmonary lymphangiectasia.
MATERIALS AND METHODS: Chest US was performed on 26 children with hypoplastic left heart syndrome, total anomalous pulmonary venous connection or cor triatriatum in a prospective observational study. Thirteen children had pulmonary venous obstruction (62% male; median age: 17 days old, range: 1-430 days old) and 13 children did not have obstruction (62% male; median age: 72 days old, range: 4-333 days old). US features of secondary pulmonary lymphangiectasia were documented and diagnostic performance was determined. Clinical course of patients with secondary pulmonary lymphangiectasia was reviewed.
RESULTS: Eleven of 13 (84.6%) patients in the obstructed group had a clinical and/or biopsy diagnosis of secondary pulmonary lymphangiectasia. Statistically significant chest US criteria for diagnosis were presence of irregular lung surface (likelihood ratio [LR] 6.8, 95% confidence interval [CI] 1.9-25.1), subpleural cystic appearing structures (LR 3.6, 95% CI 1.2-10.7), and combination of subpleural cystic appearing structures and surface irregularity together (LR 10.9, 95% CI 1.6-75.0). Seven of 11 (63.6%) patients with secondary pulmonary lymphangiectasia died during follow-up, the majority due to cardiopulmonary failure or complications.
CONCLUSION: Chest US is an accurate and reproducible bedside method for diagnosing secondary pulmonary lymphangiectasia in patients with pulmonary venous obstruction. These patients may have worse prognoses.
引用
- Lam CZ, Bhamare TA, Gazzaz T, et al. Diagnosis of secondary pulmonary lymphangiectasia in congenital heart disease: a novel role for chest ultrasound and prognostic implications. Pediatr Radiol. 2017. PMID: 28631156. doi:10.1007/s00247-017-3892-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。